-
Assessing the Impact of Exagamglogene Autotemcel (Exa-cel) on Health Inequalities in Patients with Sickle Cell Disease in the United Kingdom and Canada
Mar 10, 2025, 14:00 PM -
Patient Value Assessment Using a Unified Measure Based on Data Envelopment Analysis: A Case Study
Mar 10, 2025, 14:00 PM -
The Prevalence Of Multi-Comorbid Patients In The US: The Potential For Benefit Being Greater Than Bargained For And The Need For Multi-Indication Value Assessment
Mar 10, 2025, 14:00 PM -
Association of Systemic Lupus Erythematosus and Psychosocial Outcomes: Analysis of a Nationally Representative Data, 2017-2022
Mar 10, 2025, 14:00 PM -
Target Aggregate Data Adjustment Method (TADA): A Solution for Performing Transportability Analysis with Only Aggregate-Level Data in the Target Population
Mar 10, 2025, 14:00 PM -
The Use of Social Media Listening to Collect Oncology-Specific Patient Experience Data: A Scoping Review
Mar 10, 2025, 14:00 PM -
Integrating Dynamic Pricing Into Cost-Effectiveness Models: Implications for US-Based Drug Evaluations
Mar 10, 2025, 14:00 PM -
Reliability of Insurance Claims to Categorize Obesity in Patients with Obstructive Sleep Apnea
Mar 10, 2025, 14:00 PM -
Comparing Predicted vs. Real-World Spending in the United States for Single-Administration Cell and Gene Therapies
Mar 10, 2025, 14:00 PM -
Estimating Costs Of Dispensing Services In Community Pharmacies In Taiwan Using A Time-Driven Activity-Based Costing Approach
Mar 10, 2025, 14:00 PM -
Associations Between Post-Diagnostic Statin Use, Cholesterol Levels, and Mortality Risk Among American Breast Cancer Patients: Insights from the National Health and Nutrition (NHANES) Survey
Mar 10, 2025, 14:00 PM -
Follow Me, If You Can: How Tokenized Linkage Extends Patient Observations in Real-World Databases - the Komodo Research Dataset Example
Mar 10, 2025, 14:00 PM -
Humanistic Burden in Metastatic Triple-Negative Breast Cancer (mTNBC): A Systematic Literature Review (SLR)
Mar 10, 2025, 14:00 PM -
Which Strategy is More Effective in Patients with Rheumatoid Arthritis (RA) and Metotrexate Failure: Adding Leflunomide or TNFi?
Mar 10, 2025, 14:00 PM -
Extrapolation of Impact on Individual Patient Outcomes in Neuromyelitis Optica Spectrum Disorder (NMOSD) Due to Relapse Reduction From Ravulizumab and Other Novel Biologic Treatments
Mar 10, 2025, 14:00 PM -
Determination of Medication Regimen Complexity Trends in Older Adult Patients With Insomnia: A Triangulation of Findings From Artificial Neural Network and Logistic Regression Analyses
Mar 10, 2025, 14:00 PM -
Incorporating Social Drivers of Health Information Into Health Economics and Outcomes Research: Neighborhood-Level Proxies Versus Individual Level Data
Mar 10, 2025, 14:00 PM -
Taletrectinib vs Entrectinib in ROS1-Positive (ROS1+) Non-Small Cell Lung Cancer (NSCLC): A Matching-Adjusted Indirect Comparison (MAIC)
Mar 10, 2025, 14:00 PM -
Does Health Plan Enrollment Data Support Long-term Follow-up of Patients with Chronic Disease? Assessment of the Healthcare Integrated Research Database (HIRD®)
Mar 10, 2025, 14:00 PM -
Learnings from State and Federal Drug Pricing Negotiations Across the United States: the Impact of Prescription Drug Affordability Boards
Mar 10, 2025, 14:00 PM
